{"id":380,"date":"2011-11-23T16:21:29","date_gmt":"2011-11-23T16:21:29","guid":{"rendered":"https:\/\/blogs.bmj.com\/case-reports\/?p=380"},"modified":"2011-11-23T16:21:29","modified_gmt":"2011-11-23T16:21:29","slug":"unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/","title":{"rendered":"Unilateral onycholysis in a patient taking erlotinib (Tarceva)"},"content":{"rendered":"<p><strong>Rare side effect of treatment<\/strong><\/p>\n<p>Here the authors present a case of unilateral onycholysis in a patient receiving an EGFR tyrosine kinase inhibitor.  In addition to describing a possible mechanism for this side effect, the authors also highlight the benefits of targeted therapy. <\/p>\n<p><em>Seema Biswas<br \/>\nEditor-in-Chief<\/em><\/p>\n<p><a href=\"http:\/\/casereports.bmj.com\/content\/2011\/bcr.04.2011.4157.full\">Unilateral onycholysis in a patient taking erlotinib (Tarceva)<\/a><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rare side effect of treatment Here the authors present a case of unilateral onycholysis in a patient receiving an EGFR tyrosine kinase inhibitor. In addition to describing a possible mechanism for this side effect, the authors also highlight the benefits of targeted therapy. Seema Biswas Editor-in-Chief Unilateral onycholysis in a patient taking erlotinib (Tarceva) [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":142,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[203,2647],"tags":[],"class_list":["post-380","post","type-post","status-publish","format-standard","hentry","category-editors-choice","category-the-place-of-case-reports-in-medical-literature"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Unilateral onycholysis in a patient taking erlotinib (Tarceva) - BMJ Case Reports blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Unilateral onycholysis in a patient taking erlotinib (Tarceva) - BMJ Case Reports blog\" \/>\n<meta property=\"og:description\" content=\"Rare side effect of treatment Here the authors present a case of unilateral onycholysis in a patient receiving an EGFR tyrosine kinase inhibitor. In addition to describing a possible mechanism for this side effect, the authors also highlight the benefits of targeted therapy. Seema Biswas Editor-in-Chief Unilateral onycholysis in a patient taking erlotinib (Tarceva) [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/\" \/>\n<meta property=\"og:site_name\" content=\"BMJ Case Reports blog\" \/>\n<meta property=\"article:published_time\" content=\"2011-11-23T16:21:29+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Unilateral onycholysis in a patient taking erlotinib (Tarceva)\",\"datePublished\":\"2011-11-23T16:21:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/\"},\"wordCount\":62,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\"},\"articleSection\":[\"Editors choice\",\"The place of case reports in medical literature\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/\",\"name\":\"Unilateral onycholysis in a patient taking erlotinib (Tarceva) - BMJ Case Reports blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#website\"},\"datePublished\":\"2011-11-23T16:21:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/2011\\\/11\\\/23\\\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Unilateral onycholysis in a patient taking erlotinib (Tarceva)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\",\"name\":\"BMJ Case Reports blog\",\"description\":\"The official BMJ Case Reports blog, a place to discuss wider medical progress and implications.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#organization\",\"name\":\"BMJ Case Reports blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/files\\\/2017\\\/10\\\/blog-logo-case-reports.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/files\\\/2017\\\/10\\\/blog-logo-case-reports.png\",\"width\":224,\"height\":34,\"caption\":\"BMJ Case Reports blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/case-reports\\\/author\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Unilateral onycholysis in a patient taking erlotinib (Tarceva) - BMJ Case Reports blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/","og_locale":"en_US","og_type":"article","og_title":"Unilateral onycholysis in a patient taking erlotinib (Tarceva) - BMJ Case Reports blog","og_description":"Rare side effect of treatment Here the authors present a case of unilateral onycholysis in a patient receiving an EGFR tyrosine kinase inhibitor. In addition to describing a possible mechanism for this side effect, the authors also highlight the benefits of targeted therapy. Seema Biswas Editor-in-Chief Unilateral onycholysis in a patient taking erlotinib (Tarceva) [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/","og_site_name":"BMJ Case Reports blog","article_published_time":"2011-11-23T16:21:29+00:00","twitter_card":"summary_large_image","twitter_misc":{"Written by":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/"},"author":{"name":"","@id":""},"headline":"Unilateral onycholysis in a patient taking erlotinib (Tarceva)","datePublished":"2011-11-23T16:21:29+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/"},"wordCount":62,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization"},"articleSection":["Editors choice","The place of case reports in medical literature"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/","url":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/","name":"Unilateral onycholysis in a patient taking erlotinib (Tarceva) - BMJ Case Reports blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#website"},"datePublished":"2011-11-23T16:21:29+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/case-reports\/2011\/11\/23\/unilateral-onycholysis-in-a-patient-taking-erlotinib-tarceva\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/case-reports\/"},{"@type":"ListItem","position":2,"name":"Unilateral onycholysis in a patient taking erlotinib (Tarceva)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/case-reports\/#website","url":"https:\/\/blogs.bmj.com\/case-reports\/","name":"BMJ Case Reports blog","description":"The official BMJ Case Reports blog, a place to discuss wider medical progress and implications.","publisher":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/case-reports\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/case-reports\/#organization","name":"BMJ Case Reports blog","url":"https:\/\/blogs.bmj.com\/case-reports\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/case-reports\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/case-reports\/files\/2017\/10\/blog-logo-case-reports.png","contentUrl":"https:\/\/blogs.bmj.com\/case-reports\/files\/2017\/10\/blog-logo-case-reports.png","width":224,"height":34,"caption":"BMJ Case Reports blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/case-reports\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/blogs.bmj.com\/case-reports\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts\/380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/users\/142"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/comments?post=380"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/posts\/380\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/media?parent=380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/categories?post=380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/case-reports\/wp-json\/wp\/v2\/tags?post=380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}